Wednesday, Jun 19, 2013 8:06am EDT
ISIS - Isis Pharmaceuticals Inc - Insider Transactions
SEC Form 4 |
Date |
Sym |
Company |
Insider |
Title |
Shares |
Transaction |
Value |
|---|---|---|---|---|---|---|---|---|
Jun 11 2013 | ISIS | Isis Pharmaceuticals Inc | Monia Brett P | SVP, Antisense Drug Discovery | 9,375 | Option exercise at $15.75 | $147,656 | |
Jun 11 2013 | ISIS | Isis Pharmaceuticals Inc | Monia Brett P | SVP, Antisense Drug Discovery | 9,375 | Sale at $23.76 | $222,750 | |
May 30 2013 | ISIS | Isis Pharmaceuticals Inc | Muto Frederick T | Director | 10,000 | Option exercise at $5.17 | $51,700 | |
May 30 2013 | ISIS | Isis Pharmaceuticals Inc | Muto Frederick T | Director | 10,000 | Sale at $21.96 | $219,600 | |
MApr 30 2013 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP, Antisense Research | 59,945 | Option exercise at $9.41 | $564,010 | |
MApr 30 2013 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP, Antisense Research | 59,945 | Sale at $22.38 | $1,341,759 | |
MApr 24 2013 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | COO, Secretary | 55,854 | Option exercise at $9.70 | $541,792 | |
MApr 24 2013 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | COO, Secretary | 55,854 | Sale at $22.29 | $1,245,186 | |
Apr 24 2013 | ISIS | Isis Pharmaceuticals Inc | Hougen Elizabeth L | SVP, Finance, CFO | 10,417 | Option exercise at $15.38 | $160,213 | |
Apr 24 2013 | ISIS | Isis Pharmaceuticals Inc | Hougen Elizabeth L | SVP, Finance, CFO | 10,417 | Sale at $22.38 | $233,132 | |
Apr 24 2013 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, CEO, President | 10,000 | Sale at $22.12 | $221,200 | |
MApr 19 2013 | ISIS | Isis Pharmaceuticals Inc | O'Neil Patrick R. | SVP, Legal, General Counsel | 42,320 | Option exercise at $13.83 | $585,141 | |
MApr 19 2013 | ISIS | Isis Pharmaceuticals Inc | O'Neil Patrick R. | SVP, Legal, General Counsel | 42,320 | Sale at $21.50 | $910,028 | |
MApr 19 2013 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | COO, Secretary | 90,000 | Option exercise at $8.88 | $798,800 | |
MApr 19 2013 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | COO, Secretary | 90,000 | Sale at $21.03 | $1,892,781 | |
MApr 19 2013 | ISIS | Isis Pharmaceuticals Inc | Monia Brett P | SVP, Antisense Drug Discovery | 19,500 | Option exercise at $11.12 | $216,840 | |
MApr 19 2013 | ISIS | Isis Pharmaceuticals Inc | Monia Brett P | SVP, Antisense Drug Discovery | 19,500 | Sale at $21.26 | $414,545 | |
MApr 19 2013 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, CEO, President | 50,000 | Option exercise at $7.26 | $363,000 | |
MApr 19 2013 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, CEO, President | 90,000 | Sale at $21.03 | $1,892,781 | |
MApr 22 2013 | ISIS | Isis Pharmaceuticals Inc | Hougen Elizabeth L | SVP, Finance, CFO | 17,656 | Option exercise at $14.87 | $262,592 | |
MApr 22 2013 | ISIS | Isis Pharmaceuticals Inc | Hougen Elizabeth L | SVP, Finance, CFO | 17,656 | Sale at $21.46 | $378,814 | |
Apr 19 2013 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP, Development | 2,042 | Option exercise at $11.12 | $22,707 | |
Apr 19 2013 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP, Development | 2,042 | Sale at $20.80 | $42,474 | |
MApr 12 2013 | ISIS | Isis Pharmaceuticals Inc | O'Neil Patrick R. | SVP, Legal, General Counsel | 5,460 | Option exercise at $14.24 | $77,751 | |
MApr 12 2013 | ISIS | Isis Pharmaceuticals Inc | O'Neil Patrick R. | SVP, Legal, General Counsel | 5,460 | Sale at $19.61 | $107,096 | |
Apr 11 2013 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP, Development | 7,000 | Option exercise at $11.12 | $77,840 | |
Apr 11 2013 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP, Development | 7,000 | Sale at $19.52 | $136,640 | |
Mar 21 2013 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP, Development | 1,000 | Option exercise at $11.12 | $11,120 | |
Mar 21 2013 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP, Development | 1,000 | Sale at $19.50 | $19,500 | |
Mar 21 2013 | ISIS | Isis Pharmaceuticals Inc | O'Neil Patrick R. | SVP, Legal, General Counsel | 9,000 | Option exercise at $14.18 | $127,620 | |
Mar 21 2013 | ISIS | Isis Pharmaceuticals Inc | O'Neil Patrick R. | SVP, Legal, General Counsel | 9,000 | Sale at $19.26 | $173,340 | |
MMar 20 2013 | ISIS | Isis Pharmaceuticals Inc | Hougen Elizabeth L | SVP, Finance, CFO | 14,376 | Option exercise at $11.12 | $159,861 | |
MMar 20 2013 | ISIS | Isis Pharmaceuticals Inc | Hougen Elizabeth L | SVP, Finance, CFO | 14,376 | Sale at $18.13 | $260,637 | |
MMar 20 2013 | ISIS | Isis Pharmaceuticals Inc | Klein Joseph III | Director | 3,924 | Option exercise at $13.60 | $53,357 | |
MMar 20 2013 | ISIS | Isis Pharmaceuticals Inc | Klein Joseph III | Director | 3,924 | Sale at $18.00 | $70,632 | |
MMar 19 2013 | ISIS | Isis Pharmaceuticals Inc | Klein Joseph III | Director | 42,776 | Option exercise at $10.55 | $451,274 | |
MMar 19 2013 | ISIS | Isis Pharmaceuticals Inc | Klein Joseph III | Director | 42,776 | Sale at $18.00 | $769,968 | |
MMar 13 2013 | ISIS | Isis Pharmaceuticals Inc | Klein Joseph III | Director | 20,800 | Option exercise at $5.20 | $108,144 | |
MMar 13 2013 | ISIS | Isis Pharmaceuticals Inc | Klein Joseph III | Director | 20,800 | Sale at $18.01 | $374,544 | |
Mar 5 2013 | ISIS | Isis Pharmaceuticals Inc | Hougen Elizabeth L | SVP, Finance, CFO | 5,040 | Option exercise at $6.81 | $34,322 | |
Mar 5 2013 | ISIS | Isis Pharmaceuticals Inc | Hougen Elizabeth L | SVP, Finance, CFO | 5,040 | Sale at $16.86 | $84,960 | |
Mar 5 2013 | ISIS | Isis Pharmaceuticals Inc | Monia Brett P | SVP, Antisense Drug Discovery | 18,240 | Option exercise at $6.81 | $124,214 | |
Mar 5 2013 | ISIS | Isis Pharmaceuticals Inc | Monia Brett P | SVP, Antisense Drug Discovery | 18,240 | Sale at $16.86 | $307,599 | |
MMar 4 2013 | ISIS | Isis Pharmaceuticals Inc | O'Neil Patrick R. | SVP, Legal, General Counsel | 11,700 | Option exercise at $11.25 | $131,657 | |
MMar 4 2013 | ISIS | Isis Pharmaceuticals Inc | O'Neil Patrick R. | SVP, Legal, General Counsel | 11,700 | Sale at $15.82 | $185,059 | |
Feb 21 2013 | ISIS | Isis Pharmaceuticals Inc | Berthelsen Spencer R | Director | 10,000 | Option exercise at $5.17 | $51,700 | |
MFeb 15 2013 | ISIS | Isis Pharmaceuticals Inc | O'Neil Patrick R. | SVP, Legal, General Counsel | 1,950 | Option exercise at $10.29 | $20,066 | |
MFeb 15 2013 | ISIS | Isis Pharmaceuticals Inc | O'Neil Patrick R. | SVP, Legal, General Counsel | 1,950 | Sale at $14.80 | $28,865 | |
MFeb 13 2013 | ISIS | Isis Pharmaceuticals Inc | O'Neil Patrick R. | SVP, Legal, General Counsel | 6,100 | Option exercise at $7.36 | $44,900 | |
MFeb 13 2013 | ISIS | Isis Pharmaceuticals Inc | O'Neil Patrick R. | SVP, Legal, General Counsel | 6,239 | Sale at $14.17 | $88,407 | |
MJan 29 2013 | ISIS | Isis Pharmaceuticals Inc | O'Neil Patrick R. | SVP, Legal, General Counsel | 2,300 | Sale at $14.63 | $33,660 | |
Jan 30 2013 | ISIS | Isis Pharmaceuticals Inc | O'Neil Patrick R. | SVP, Legal, General Counsel | 2,000 | Option exercise at $10.29 | $20,580 | |
Jan 15 2013 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP, Antisense Research | 695 | Option exercise at $0.00 | $0 | |
Jan 16 2013 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP, Antisense Research | 309 | Sale at $14.00 | $4,326 | |
Jan 15 2013 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP, Development | 776 | Option exercise at $0.00 | $0 | |
Jan 16 2013 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP, Development | 345 | Sale at $14.00 | $4,830 | |
MJan 15 2013 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, CEO, President | 3,295 | Option exercise at $0.00 | $0 | |
MJan 16 2013 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, CEO, President | 1,460 | Sale at $14.00 | $20,440 | |
MJan 15 2013 | ISIS | Isis Pharmaceuticals Inc | Monia Brett P | SVP, Antisense Drug Discovery | 737 | Option exercise at $0.00 | $0 | |
MJan 16 2013 | ISIS | Isis Pharmaceuticals Inc | Monia Brett P | SVP, Antisense Drug Discovery | 330 | Sale at $14.00 | $4,620 | |
Jan 15 2013 | ISIS | Isis Pharmaceuticals Inc | Hougen Elizabeth L | SVP, Finance, CFO | 542 | Option exercise at $0.00 | $0 | |
Jan 16 2013 | ISIS | Isis Pharmaceuticals Inc | Hougen Elizabeth L | SVP, Finance, CFO | 242 | Sale at $14.00 | $3,388 | |
Jan 15 2013 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | COO, Secretary | 1,715 | Option exercise at $0.00 | $0 | |
Jan 16 2013 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | COO, Secretary | 759 | Sale at $14.00 | $10,626 | |
Jan 15 2013 | ISIS | Isis Pharmaceuticals Inc | O'Neil Patrick R. | SVP, Legal, General Counsel | 542 | Option exercise at $0.00 | $0 | |
Jan 17 2013 | ISIS | Isis Pharmaceuticals Inc | O'Neil Patrick R. | SVP, Legal, General Counsel | 242 | Sale at $14.16 | $3,427 | |
Jan 4 2013 | ISIS | Isis Pharmaceuticals Inc | O'Neil Patrick R. | SVP, Legal, General Counsel | 1,296 | Sale at $10.76 | $13,945 | |
Jan 1 2013 | ISIS | Isis Pharmaceuticals Inc | O'Neil Patrick R. | SVP, Legal, General Counsel | 431 | Other Purchase at $8.87 | $3,825 | |
Jan 1 2013 | ISIS | Isis Pharmaceuticals Inc | Monia Brett P | VP, Antisense Drug Discovery | 215 | Other Purchase at $8.87 | $1,908 | |
Jan 3 2013 | ISIS | Isis Pharmaceuticals Inc | Monia Brett P | VP, Antisense Drug Discovery | 311 | Sale at $10.84 | $3,371 | |
Jan 1 2013 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP, Antisense Research | 447 | Other Purchase at $8.87 | $3,967 | |
Jan 1 2013 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP, Development | 898 | Other Purchase at $8.87 | $7,969 | |
Jan 3 2013 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP, Development | 265 | Sale at $10.84 | $2,873 | |
Dec 13 2012 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP, Development | 6,000 | Option exercise at $5.25 | $31,500 | |
Dec 13 2012 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP, Development | 6,000 | Sale at $9.63 | $57,751 | |
MSep 19 2012 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, CEO, President | 89,462 | Option exercise at $6.14 | $549,176 | |
MSep 19 2012 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, CEO, President | 89,462 | Sale at $14.63 | $1,308,926 | |
Sep 13 2012 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, CEO, President | 27,074 | Option exercise at $5.25 | $142,139 | |
Sep 13 2012 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, CEO, President | 27,074 | Sale at $14.55 | $393,927 | |
MSep 7 2012 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | COO, Secretary | 12,506 | Option exercise at $6.84 | $85,541 | |
MSep 7 2012 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | COO, Secretary | 12,506 | Sale at $15.12 | $189,091 | |
MSep 4 2012 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | COO, Secretary | 62,000 | Option exercise at $5.57 | $345,365 | |
MSep 4 2012 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | COO, Secretary | 62,000 | Sale at $15.01 | $930,585 | |
MSep 4 2012 | ISIS | Isis Pharmaceuticals Inc | Reed John C | Director | 10,000 | Option exercise at $5.17 | $51,700 | |
MSep 4 2012 | ISIS | Isis Pharmaceuticals Inc | Reed John C | Director | 10,000 | Sale at $15.17 | $151,725 | |
Sep 6 2012 | ISIS | Isis Pharmaceuticals Inc | Monia Brett P | VP, Antisense Drug Discovery | 12,031 | Option exercise at $5.25 | $63,163 | |
Sep 6 2012 | ISIS | Isis Pharmaceuticals Inc | Monia Brett P | VP, Antisense Drug Discovery | 12,031 | Sale at $15.25 | $183,473 | |
MSep 4 2012 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, CEO, President | 75,000 | Option exercise at $5.29 | $396,811 | |
MSep 4 2012 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, CEO, President | 75,000 | Sale at $14.62 | $1,096,155 | |
MJul 9 2012 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP, Antisense Research | 10,500 | Option exercise at $6.83 | $71,670 | |
MJul 9 2012 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP, Antisense Research | 10,500 | Sale at $13.51 | $141,855 | |
MJul 9 2012 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP, Development | 5,686 | Option exercise at $5.25 | $29,852 | |
MJul 9 2012 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP, Development | 5,686 | Sale at $13.47 | $76,610 | |
Jul 9 2012 | ISIS | Isis Pharmaceuticals Inc | Reed John C | Director | 10,000 | Option exercise at $3.95 | $39,500 | |
Jul 9 2012 | ISIS | Isis Pharmaceuticals Inc | Reed John C | Director | 10,000 | Sale at $13.99 | $139,900 | |
Jul 1 2012 | ISIS | Isis Pharmaceuticals Inc | Monia Brett P | SVP, Antisense Drug Discovery | 311 | Other Purchase at $6.13 | $1,906 | |
Jul 3 2012 | ISIS | Isis Pharmaceuticals Inc | Monia Brett P | SVP, Antisense Drug Discovery | 587 | Sale at $12.92 | $7,584 | |
Jul 1 2012 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP, Antisense Research | 648 | Other Purchase at $6.13 | $3,971 | |
Jul 3 2012 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP, Antisense Research | 6,000 | Option exercise at $6.84 | $41,040 | |
Jul 3 2012 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP, Antisense Research | 6,000 | Sale at $12.91 | $77,460 | |
Jul 1 2012 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP, Development | 1,300 | Other Purchase at $6.13 | $7,967 | |
Jul 3 2012 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP, Development | 2,434 | Sale at $12.91 | $31,423 | |
MJun 25 2012 | ISIS | Isis Pharmaceuticals Inc | Berthelsen Spencer R | Director | 10,000 | Option exercise at $8.15 | $81,500 | |
MJun 25 2012 | ISIS | Isis Pharmaceuticals Inc | Berthelsen Spencer R | Director | 10,000 | Sale at $11.57 | $115,669 | |
Jun 22 2012 | ISIS | Isis Pharmaceuticals Inc | Reed John C | Director | 10,000 | Option exercise at $8.15 | $81,500 | |
Jun 22 2012 | ISIS | Isis Pharmaceuticals Inc | Reed John C | Director | 10,000 | Sale at $11.06 | $110,600 | |
Jun 14 2012 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP, Development | 1,579 | Sale at $10.86 | $17,148 | |
Jun 12 2012 | ISIS | Isis Pharmaceuticals Inc | Wender Joseph H | Director | 10,000 | Option exercise at $8.15 | $81,500 | |
MMay 21 2012 | ISIS | Isis Pharmaceuticals Inc | Berthelsen Spencer R | Director | 20,000 | Option exercise at $9.40 | $188,000 | |
MMay 21 2012 | ISIS | Isis Pharmaceuticals Inc | Berthelsen Spencer R | Director | 20,000 | Sale at $9.54 | $190,818 | |
Jan 1 2012 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 324 | Other Purchase at $6.13 | $1,986 | |
Jan 1 2012 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP | 1,625 | Other Purchase at $6.13 | $9,959 | |
Dec 1 2011 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 324 | Other Purchase at $6.13 | $1,986 | |
Jan 1 2012 | ISIS | Isis Pharmaceuticals Inc | Monia Brett P | SVP | 587 | Other Sale at $6.13 | $3,597 | |
Dec 21 2011 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP | 1,144 | Option exercise at $5.80 | $6,635 | |
Dec 21 2011 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP | 1,144 | Sale at $6.92 | $7,916 | |
MDec 21 2011 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 17,800 | Option exercise at $5.80 | $103,240 | |
MDec 21 2011 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 17,800 | Sale at $6.92 | $123,176 | |
MDec 21 2011 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 6,763 | Option exercise at $5.80 | $39,225 | |
MDec 21 2011 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 6,763 | Sale at $6.92 | $46,800 | |
Dec 21 2011 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 1,555 | Option exercise at $5.80 | $9,019 | |
Dec 21 2011 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 1,555 | Sale at $6.92 | $10,761 | |
MDec 16 2011 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 63,300 | Option exercise at $5.80 | $367,140 | |
MDec 16 2011 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 63,300 | Sale at $6.82 | $431,896 | |
MDec 16 2011 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 5,500 | Option exercise at $5.80 | $31,900 | |
MDec 16 2011 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 5,500 | Sale at $6.82 | $37,528 | |
MDec 16 2011 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP | 3,900 | Option exercise at $5.80 | $22,620 | |
MDec 16 2011 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP | 3,900 | Sale at $6.82 | $26,607 | |
MDec 16 2011 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 23,500 | Option exercise at $55.99 | $1,315,707 | |
MDec 16 2011 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 23,500 | Sale at $6.82 | $160,359 | |
Aug 4 2011 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 10,000 | Option exercise at $5.25 | $52,500 | |
Aug 4 2011 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 10,000 | Sale at $7.62 | $76,206 | |
Jul 28 2011 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 1,000 | Sale at $8.60 | $8,600 | |
Jul 1 2011 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 251 | Other Purchase at $7.91 | $1,984 | |
Jul 1 2011 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP | 265 | Other Purchase at $7.91 | $2,095 | |
Jan 1 2011 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 493 | Other Purchase at $7.79 | $3,843 | |
Jan 1 2011 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP | 2,434 | Other Purchase at $7.79 | $18,972 | |
MDec 27 2010 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP | 5,280 | Option exercise at $9.62 | $50,820 | |
MDec 27 2010 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP | 5,280 | Sale at $10.38 | $54,810 | |
MDec 27 2010 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 17,200 | Option exercise at $9.62 | $165,550 | |
MDec 27 2010 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 17,200 | Sale at $10.38 | $178,552 | |
MDec 27 2010 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 12,300 | Option exercise at $9.62 | $118,388 | |
MDec 27 2010 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 12,300 | Sale at $10.38 | $127,683 | |
MDec 27 2010 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 32,000 | Option exercise at $9.62 | $308,000 | |
MDec 27 2010 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 32,000 | Sale at $10.38 | $332,180 | |
Dec 23 2010 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP | 200 | Option exercise at $9.62 | $1,925 | |
Dec 23 2010 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP | 200 | Sale at $10.53 | $2,105 | |
MDec 22 2010 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | COO | 15,150 | Option exercise at $9.88 | $149,712 | |
MDec 22 2010 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | COO | 6,450 | Sale at $10.52 | $67,865 | |
MDec 22 2010 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP | 3,000 | Option exercise at $9.62 | $28,875 | |
MDec 22 2010 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP | 3,000 | Sale at $10.52 | $31,562 | |
MDec 22 2010 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 7,700 | Option exercise at $9.62 | $74,113 | |
MDec 22 2010 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 7,700 | Sale at $10.52 | $81,012 | |
MDec 22 2010 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 20,000 | Option exercise at $9.62 | $192,500 | |
MDec 22 2010 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 20,000 | Sale at $10.52 | $210,420 | |
Jul 23 2010 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 1,100 | Sale at $9.60 | $10,560 | |
Jul 1 2010 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 490 | Other Purchase at $7.84 | $3,840 | |
MJun 28 2010 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 10,000 | Option exercise at $5.80 | $58,000 | |
MJun 28 2010 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 10,000 | Sale at $9.89 | $98,950 | |
Jan 1 2010 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 195 | Other Purchase at $9.44 | $1,841 | |
Jan 1 2010 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP | 1,579 | Other Purchase at $9.44 | $14,911 | |
MDec 31 2009 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 7,090 | Option exercise at $6.81 | $48,301 | |
MDec 31 2009 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 7,090 | Sale at $11.21 | $79,479 | |
MDec 28 2009 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 8,000 | Option exercise at $6.81 | $54,500 | |
MDec 28 2009 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 8,000 | Sale at $11.09 | $88,730 | |
Dec 30 2009 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 6,535 | Option exercise at $6.81 | $44,503 | |
Dec 30 2009 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 6,535 | Sale at $11.06 | $72,310 | |
Dec 30 2009 | ISIS | Isis Pharmaceuticals Inc | Wender Joseph H | Director | 10,000 | Option exercise at $6.81 | $68,100 | |
Dec 22 2009 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 20,000 | Option exercise at $6.81 | $136,250 | |
Dec 22 2009 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 20,000 | Sale at $10.13 | $202,600 | |
MDec 22 2009 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 26,910 | Option exercise at $6.81 | $183,324 | |
MDec 22 2009 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 26,910 | Sale at $10.42 | $280,377 | |
Dec 15 2009 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 1,000 | Option exercise at $6.25 | $6,250 | |
Dec 15 2009 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 1,000 | Sale at $10.03 | $10,030 | |
Dec 15 2009 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 10,000 | Option exercise at $6.81 | $68,125 | |
Dec 15 2009 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 10,000 | Sale at $10.03 | $100,300 | |
MDec 15 2009 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 50,000 | Option exercise at $6.81 | $340,625 | |
MDec 15 2009 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 50,000 | Sale at $10.07 | $503,260 | |
MDec 10 2009 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 23,000 | Option exercise at $6.81 | $156,688 | |
MDec 10 2009 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 23,000 | Sale at $10.08 | $231,750 | |
MDec 10 2009 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 70,000 | Option exercise at $6.81 | $476,875 | |
MDec 10 2009 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 70,000 | Sale at $10.02 | $701,300 | |
MDec 8 2009 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 50,000 | Option exercise at $6.81 | $340,625 | |
MDec 8 2009 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 50,000 | Sale at $10.42 | $521,100 | |
MDec 8 2009 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 30,000 | Option exercise at $6.81 | $204,375 | |
MDec 8 2009 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 30,000 | Sale at $10.44 | $313,200 | |
MDec 4 2009 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 45,000 | Option exercise at $6.81 | $306,563 | |
MDec 4 2009 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 45,000 | Sale at $10.53 | $474,000 | |
MDec 4 2009 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 60,000 | Option exercise at $6.81 | $408,750 | |
MDec 4 2009 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 60,000 | Sale at $10.54 | $632,100 | |
Jul 23 2009 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 12,000 | Option exercise at $6.81 | $81,720 | |
Jul 23 2009 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 12,000 | Sale at $17.03 | $204,307 | |
Jul 6 2009 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 876 | Sale at $15.71 | $13,762 | |
Jul 1 2009 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 289 | Other Purchase at $12.30 | $3,555 | |
Jul 1 2009 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP | 387 | Other Purchase at $12.30 | $4,760 | |
Jul 2 2009 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP | 387 | Sale at $15.89 | $6,148 | |
Apr 22 2009 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 10,000 | Option exercise at $6.81 | $68,100 | |
Apr 22 2009 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 10,000 | Sale at $15.92 | $159,200 | |
Apr 7 2009 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 10,000 | Option exercise at $6.81 | $68,100 | |
Apr 7 2009 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 10,000 | Sale at $14.60 | $146,030 | |
Jan 5 2009 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 1,949 | Sale at $14.20 | $27,676 | |
Dec 30 2008 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 5,000 | Option exercise at $12.94 | $64,688 | |
Dec 30 2008 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 5,000 | Sale at $13.37 | $66,846 | |
Jan 1 2009 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 700 | Other Purchase at $11.65 | $8,157 | |
Jan 1 2009 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP | 1,415 | Other Purchase at $11.65 | $16,490 | |
Jan 2 2009 | ISIS | Isis Pharmaceuticals Inc | Geary Richard S | SVP | 1,415 | Sale at $14.05 | $19,887 | |
Jan 1 2009 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 150 | Other Purchase at $11.65 | $1,748 | |
Dec 30 2008 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 7,500 | Option exercise at $12.94 | $97,031 | |
Dec 30 2008 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 7,500 | Sale at $13.37 | $100,268 | |
MDec 23 2008 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 17,300 | Option exercise at $12.94 | $223,819 | |
MDec 23 2008 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 17,300 | Sale at $13.40 | $231,861 | |
MDec 23 2008 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 12,000 | Option exercise at $12.94 | $155,250 | |
MDec 23 2008 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 12,000 | Sale at $13.41 | $160,883 | |
Dec 19 2008 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 8,000 | Option exercise at $12.94 | $103,500 | |
Dec 19 2008 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 8,000 | Sale at $13.93 | $111,410 | |
MDec 19 2008 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 13,000 | Option exercise at $12.94 | $168,188 | |
MDec 19 2008 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 13,000 | Sale at $13.93 | $181,042 | |
MDec 17 2008 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 12,173 | Option exercise at $5.15 | $62,691 | |
MDec 17 2008 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 12,173 | Sale at $12.80 | $155,851 | |
Sep 2 2008 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 10,000 | Option exercise at $6.81 | $68,100 | |
Sep 2 2008 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 10,000 | Sale at $18.11 | $181,120 | |
Aug 20 2008 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 6,000 | Option exercise at $6.81 | $40,860 | |
Aug 20 2008 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 6,000 | Sale at $17.97 | $107,820 | |
Aug 22 2008 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 10,000 | Option exercise at $6.81 | $68,100 | |
Aug 22 2008 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 10,000 | Sale at $18.04 | $180,380 | |
MAug 14 2008 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 8,000 | Option exercise at $6.25 | $50,000 | |
MAug 14 2008 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 8,000 | Sale at $19.25 | $154,035 | |
MAug 11 2008 | ISIS | Isis Pharmaceuticals Inc | Klein Joseph III | Director | 10,000 | Sale at $18.58 | $185,799 | |
Aug 11 2008 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 15,000 | Option exercise at $5.80 | $87,000 | |
MAug 11 2008 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 15,000 | Sale at $18.37 | $275,577 | |
Aug 11 2008 | ISIS | Isis Pharmaceuticals Inc | Treble Michael J | VP, Pres of Ibis | 20,000 | Option exercise at $5.95 | $119,000 | |
MAug 11 2008 | ISIS | Isis Pharmaceuticals Inc | Treble Michael J | VP, Pres of Ibis | 20,000 | Sale at $18.45 | $369,060 | |
Aug 11 2008 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 15,000 | Option exercise at $12.94 | $194,063 | |
MAug 11 2008 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 15,000 | Sale at $18.28 | $274,178 | |
Jul 1 2008 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 145 | Other Purchase at $11.80 | $1,711 | |
Jul 1 2008 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 1,285 | Other Purchase at $11.80 | $15,160 | |
Jul 3 2008 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 1,338 | Sale at $13.91 | $18,616 | |
Jul 3 2008 | ISIS | Isis Pharmaceuticals Inc | Wender Joseph H | Director | 4,000 | Sale at $13.94 | $55,760 | |
Jun 30 2008 | ISIS | Isis Pharmaceuticals Inc | Wender Joseph H | Director | 4,000 | Option exercise at $13.25 | $53,000 | |
May 19 2008 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 1,500 | Gift at $0.00 | $0 | |
Apr 10 2008 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 5,300 | Option exercise at $6.84 | $36,252 | |
Apr 10 2008 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 5,300 | Sale at $16.04 | $85,023 | |
MApr 7 2008 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 12,200 | Option exercise at $6.41 | $78,248 | |
MApr 7 2008 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 12,200 | Sale at $16.07 | $196,061 | |
Apr 1 2008 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 10,000 | Option exercise at $5.25 | $52,500 | |
Apr 1 2008 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 10,000 | Sale at $15.33 | $153,300 | |
Jan 8 2008 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 2,406 | Sale at $19.28 | $46,388 | |
Jan 1 2008 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 2,065 | Other Purchase at $8.30 | $17,142 | |
Jan 4 2008 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 3,000 | Gift at $0.00 | $0 | |
Jan 1 2008 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | SVP | 195 | Other Purchase at $8.30 | $1,619 | |
Jan 1 2008 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | Director, COO | 876 | Other Purchase at $8.30 | $7,275 | |
MDec 26 2007 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 52,100 | Option exercise at $12.31 | $641,481 | |
MDec 26 2007 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 50,000 | Sale at $16.38 | $818,975 | |
Dec 11 2007 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 20,000 | Option exercise at $12.31 | $246,250 | |
Dec 11 2007 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 20,000 | Sale at $17.37 | $347,480 | |
Nov 28 2007 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 20,000 | Option exercise at $6.81 | $136,250 | |
Nov 28 2007 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 20,000 | Sale at $18.01 | $360,220 | |
MNov 28 2007 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 59,851 | Option exercise at $5.15 | $308,233 | |
MNov 28 2007 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 59,851 | Sale at $18.02 | $1,078,484 | |
Oct 26 2007 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 3,400 | Gift at $0.00 | $0 | |
MSep 27 2007 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 45,000 | Option exercise at $12.31 | $554,063 | |
MSep 27 2007 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 45,000 | Sale at $15.23 | $685,331 | |
Sep 20 2007 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 14,000 | Option exercise at $12.31 | $172,375 | |
Sep 20 2007 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 14,000 | Sale at $14.76 | $206,570 | |
Sep 21 2007 | ISIS | Isis Pharmaceuticals Inc | Treble Michael J | VP, Head of Ibis | 10,000 | Option exercise at $5.95 | $59,500 | |
Sep 21 2007 | ISIS | Isis Pharmaceuticals Inc | Treble Michael J | VP, Head of Ibis | 10,000 | Sale at $14.95 | $149,500 | |
Sep 18 2007 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 6,000 | Option exercise at $6.81 | $40,860 | |
Sep 18 2007 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 6,000 | Sale at $14.13 | $84,780 | |
Sep 14 2007 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 10,000 | Option exercise at $5.15 | $51,500 | |
Sep 14 2007 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 10,000 | Sale at $13.76 | $137,600 | |
Sep 14 2007 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 24,000 | Option exercise at $6.81 | $163,440 | |
MSep 14 2007 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 24,000 | Sale at $14.14 | $339,244 | |
Sep 14 2007 | ISIS | Isis Pharmaceuticals Inc | Treble Michael J | VP, Head of Ibis | 10,000 | Option exercise at $5.95 | $59,500 | |
Sep 14 2007 | ISIS | Isis Pharmaceuticals Inc | Treble Michael J | VP, Head of Ibis | 10,000 | Sale at $13.96 | $139,600 | |
Sep 11 2007 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 6,466 | Option exercise at $5.15 | $33,300 | |
Sep 11 2007 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 6,466 | Sale at $13.03 | $84,252 | |
Aug 21 2007 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 10,000 | Option exercise at $6.25 | $62,500 | |
Aug 21 2007 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 10,000 | Sale at $12.50 | $125,000 | |
Jul 12 2007 | ISIS | Isis Pharmaceuticals Inc | Treble Michael J | VP, Head of Ibis | 10,000 | Option exercise at $5.95 | $59,500 | |
Jul 12 2007 | ISIS | Isis Pharmaceuticals Inc | Treble Michael J | VP, Head of Ibis | 10,000 | Sale at $11.95 | $119,500 | |
Jul 10 2007 | ISIS | Isis Pharmaceuticals Inc | Treble Michael J | VP, Head of Ibis | 10,000 | Option exercise at $5.25 | $52,500 | |
Jul 10 2007 | ISIS | Isis Pharmaceuticals Inc | Treble Michael J | VP, Head of Ibis | 10,000 | Sale at $11.95 | $119,500 | |
Jul 9 2007 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 4,599 | Option exercise at $5.15 | $23,685 | |
MJul 9 2007 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 5,732 | Sale at $10.65 | $61,073 | |
MJul 6 2007 | ISIS | Isis Pharmaceuticals Inc | Wedel Mark K | VP, Chief Medical Officer | 5,200 | Option exercise at $5.60 | $29,118 | |
Jul 6 2007 | ISIS | Isis Pharmaceuticals Inc | Wedel Mark K | VP, Chief Medical Officer | 5,200 | Sale at $10.12 | $52,626 | |
Jul 1 2007 | ISIS | Isis Pharmaceuticals Inc | Wedel Mark K | VP, Chief Medical Officer | 902 | Other Purchase at $8.23 | $7,422 | |
Jul 2 2007 | ISIS | Isis Pharmaceuticals Inc | Wedel Mark K | VP, Chief Medical Officer | 902 | Sale at $9.70 | $8,752 | |
Jul 1 2007 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 594 | Other Purchase at $8.23 | $4,887 | |
Jul 1 2007 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 197 | Other Purchase at $8.23 | $1,621 | |
Jul 1 2007 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 1,949 | Other Purchase at $8.23 | $16,036 | |
Jul 3 2007 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 835 | Sale at $9.85 | $8,225 | |
May 9 2007 | ISIS | Isis Pharmaceuticals Inc | Wedel Mark K | VP, Chief Medical Officer | 2,800 | Option exercise at $5.15 | $14,420 | |
May 9 2007 | ISIS | Isis Pharmaceuticals Inc | Wedel Mark K | VP, Chief Medical Officer | 2,800 | Sale at $10.36 | $29,019 | |
May 2 2007 | ISIS | Isis Pharmaceuticals Inc | Wedel Mark K | VP, Chief Medical Officer | 2,000 | Option exercise at $5.15 | $10,300 | |
May 2 2007 | ISIS | Isis Pharmaceuticals Inc | Wedel Mark K | VP, Chief Medical Officer | 2,000 | Sale at $10.25 | $20,500 | |
Apr 25 2007 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 6,000 | Option exercise at $5.25 | $31,500 | |
Apr 25 2007 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 6,000 | Sale at $10.11 | $60,660 | |
MApr 25 2007 | ISIS | Isis Pharmaceuticals Inc | Wedel Mark K | VP, Chief Medical Officer | 10,000 | Option exercise at $4.68 | $46,769 | |
Apr 25 2007 | ISIS | Isis Pharmaceuticals Inc | Wedel Mark K | VP, Chief Medical Officer | 13,711 | Sale at $10.11 | $138,618 | |
Jan 1 2007 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 302 | Other Purchase at $5.14 | $1,553 | |
Jan 1 2007 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 3,181 | Other Purchase at $5.14 | $16,358 | |
Jan 1 2007 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 1,338 | Other Purchase at $5.14 | $6,881 | |
Jan 1 2007 | ISIS | Isis Pharmaceuticals Inc | Wedel Mark K | VP, Chief Medical Officer | 698 | Other Purchase at $5.14 | $3,589 | |
Dec 8 2006 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 11,100 | Option exercise at $6.81 | $75,591 | |
Dec 8 2006 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 11,100 | Sale at $12.04 | $133,603 | |
Dec 4 2006 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 5,000 | Option exercise at $6.81 | $34,050 | |
Dec 4 2006 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 5,000 | Sale at $11.50 | $57,486 | |
Nov 14 2006 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 3,900 | Option exercise at $6.81 | $26,559 | |
Nov 14 2006 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 3,900 | Sale at $12.11 | $47,210 | |
MNov 9 2006 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 20,000 | Option exercise at $5.15 | $103,000 | |
MNov 9 2006 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 20,000 | Sale at $11.74 | $234,900 | |
MNov 9 2006 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 36,788 | Option exercise at $5.60 | $206,058 | |
MNov 9 2006 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 46,788 | Sale at $11.55 | $540,429 | |
MNov 9 2006 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 50,000 | Sale at $11.48 | $573,850 | |
MNov 9 2006 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 50,000 | Option exercise at $6.81 | $340,500 | |
MNov 9 2006 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 50,000 | Sale at $12.07 | $603,400 | |
MNov 9 2006 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 50,000 | Option exercise at $5.15 | $257,500 | |
MNov 9 2006 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 50,000 | Sale at $12.07 | $603,400 | |
MOct 19 2006 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 12,424 | Option exercise at $5.66 | $70,372 | |
MOct 19 2006 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 12,424 | Sale at $8.98 | $111,517 | |
Oct 6 2006 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 10,000 | Option exercise at $5.15 | $51,500 | |
MOct 6 2006 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 10,000 | Sale at $7.97 | $79,736 | |
Aug 15 2006 | ISIS | Isis Pharmaceuticals Inc | Klein Joseph III | Director | 2,000 | Purchase at $6.26 | $12,520 | |
Aug 1 2006 | ISIS | Isis Pharmaceuticals Inc | Klein Joseph III | Director | 2,000 | Purchase at $6.00 | $12,000 | |
Jul 18 2006 | ISIS | Isis Pharmaceuticals Inc | Klein Joseph III | Director | 2,000 | Purchase at $5.91 | $11,820 | |
Jul 3 2006 | ISIS | Isis Pharmaceuticals Inc | Klein Joseph III | Director | 2,000 | Purchase at $6.02 | $12,040 | |
Jul 1 2006 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 3,184 | Other Purchase at $4.45 | $14,182 | |
Jul 1 2006 | ISIS | Isis Pharmaceuticals Inc | Wedel Mark K | VP, Chief Medical Officer | 1,162 | Other Purchase at $4.45 | $5,176 | |
Jul 1 2006 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 2,406 | Other Purchase at $4.45 | $10,716 | |
Jul 1 2006 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 492 | Other Purchase at $4.45 | $2,191 | |
Jun 15 2006 | ISIS | Isis Pharmaceuticals Inc | Klein Joseph III | Director | 2,000 | Purchase at $6.40 | $12,800 | |
May 5 2006 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 8,500 | Option exercise at $5.80 | $49,300 | |
MMay 5 2006 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 8,500 | Sale at $8.56 | $72,740 | |
MMar 20 2006 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 10,000 | Option exercise at $6.84 | $68,400 | |
MMar 20 2006 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 10,000 | Sale at $9.04 | $90,373 | |
MMar 20 2006 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 26,788 | Option exercise at $5.15 | $137,958 | |
MMar 20 2006 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 26,788 | Sale at $9.04 | $242,099 | |
MMar 7 2006 | ISIS | Isis Pharmaceuticals Inc | Brown Richard K | VP | 4,770 | Option exercise at $6.84 | $32,627 | |
MMar 7 2006 | ISIS | Isis Pharmaceuticals Inc | Brown Richard K | VP | 4,770 | Sale at $8.03 | $38,283 | |
Mar 3 2006 | ISIS | Isis Pharmaceuticals Inc | Brown Richard K | VP | 1,008 | Option exercise at $6.84 | $6,895 | |
MMar 3 2006 | ISIS | Isis Pharmaceuticals Inc | Brown Richard K | VP | 1,008 | Sale at $8.20 | $8,266 | |
MMar 1 2006 | ISIS | Isis Pharmaceuticals Inc | Brown Richard K | VP | 9,600 | Option exercise at $6.83 | $65,584 | |
MMar 1 2006 | ISIS | Isis Pharmaceuticals Inc | Brown Richard K | VP | 9,600 | Sale at $8.13 | $78,032 | |
MFeb 27 2006 | ISIS | Isis Pharmaceuticals Inc | Brown Richard K | VP | 5,715 | Option exercise at $6.81 | $38,919 | |
MFeb 27 2006 | ISIS | Isis Pharmaceuticals Inc | Brown Richard K | VP | 5,715 | Sale at $8.07 | $46,146 | |
Feb 24 2006 | ISIS | Isis Pharmaceuticals Inc | Brown Richard K | VP | 1,000 | Option exercise at $6.81 | $6,810 | |
Feb 24 2006 | ISIS | Isis Pharmaceuticals Inc | Brown Richard K | VP | 1,000 | Sale at $8.02 | $8,020 | |
Feb 22 2006 | ISIS | Isis Pharmaceuticals Inc | Brown Richard K | VP | 1,185 | Option exercise at $5.80 | $6,873 | |
Feb 22 2006 | ISIS | Isis Pharmaceuticals Inc | Brown Richard K | VP | 1,185 | Sale at $7.88 | $9,338 | |
Feb 17 2006 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 26,789 | Option exercise at $5.15 | $137,963 | |
Feb 17 2006 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 26,789 | Sale at $8.02 | $214,899 | |
Feb 17 2006 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 7,770 | Option exercise at $5.15 | $40,016 | |
Feb 17 2006 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 7,770 | Sale at $8.03 | $62,393 | |
MFeb 17 2006 | ISIS | Isis Pharmaceuticals Inc | Brown Richard K | VP | 15,100 | Option exercise at $5.41 | $81,730 | |
MFeb 17 2006 | ISIS | Isis Pharmaceuticals Inc | Brown Richard K | VP | 15,100 | Sale at $8.09 | $122,231 | |
Feb 16 2006 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 3,000 | Option exercise at $5.15 | $15,450 | |
Feb 16 2006 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 3,000 | Sale at $7.95 | $23,850 | |
Feb 9 2006 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 1,500 | Sale at $6.50 | $9,750 | |
Feb 1 2006 | ISIS | Isis Pharmaceuticals Inc | Klein Joseph III | Director | 2,000 | Purchase at $5.48 | $10,960 | |
Jan 17 2006 | ISIS | Isis Pharmaceuticals Inc | Klein Joseph III | Director | 2,000 | Purchase at $5.46 | $10,920 | |
Jan 1 2006 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 190 | Other Purchase at $3.36 | $638 | |
Jan 3 2006 | ISIS | Isis Pharmaceuticals Inc | Klein Joseph III | Director | 2,000 | Purchase at $5.16 | $10,321 | |
Jan 1 2006 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 1,889 | Other Purchase at $3.36 | $6,342 | |
Jan 1 2006 | ISIS | Isis Pharmaceuticals Inc | Wedel Mark K | VP, Chief Medical Officer | 394 | Other Purchase at $3.36 | $1,323 | |
Jan 1 2006 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 835 | Other Purchase at $3.36 | $2,804 | |
Dec 15 2005 | ISIS | Isis Pharmaceuticals Inc | Klein Joseph III | Director | 2,000 | Purchase at $5.18 | $10,360 | |
MSep 16 2005 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 1,450 | Sale at $5.30 | $7,691 | |
MSep 13 2005 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 1,558 | Sale at $5.30 | $8,262 | |
MSep 8 2005 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 2,700 | Sale at $5.45 | $14,722 | |
Jul 1 2005 | ISIS | Isis Pharmaceuticals Inc | Wedel Mark K | VP, Chief Medical Officer | 856 | Other Purchase at $3.36 | $2,874 | |
Jul 1 2005 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 3,477 | Other Purchase at $3.36 | $11,674 | |
Jul 1 2005 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 591 | Other Purchase at $3.36 | $1,984 | |
Jul 1 2005 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 2,702 | Other Purchase at $3.36 | $9,072 | |
Jul 5 2005 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 2,702 | Sale at $3.85 | $10,411 | |
MJun 24 2005 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 4,446 | Sale at $4.01 | $17,808 | |
Jan 1 2005 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 182 | Other Purchase at $4.67 | $849 | |
Jan 1 2005 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 2,008 | Other Purchase at $4.67 | $9,370 | |
Jan 1 2005 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 200 | Other Purchase at $4.67 | $933 | |
Jan 1 2005 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 924 | Other Purchase at $4.67 | $4,312 | |
Dec 22 2004 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 1,000 | Option exercise at $5.88 | $5,875 | |
Dec 22 2004 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 1,000 | Sale at $6.20 | $6,200 | |
MDec 9 2004 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 8,500 | Option exercise at $5.88 | $49,938 | |
MDec 9 2004 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 8,500 | Sale at $6.17 | $52,460 | |
MDec 6 2004 | ISIS | Isis Pharmaceuticals Inc | Lowenstam Patricia | VP | 9,000 | Option exercise at $3.79 | $34,076 | |
MDec 6 2004 | ISIS | Isis Pharmaceuticals Inc | Lowenstam Patricia | VP | 9,000 | Sale at $5.82 | $52,398 | |
MDec 10 2004 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 5,500 | Option exercise at $5.88 | $32,313 | |
MDec 10 2004 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 5,500 | Sale at $6.18 | $34,010 | |
MDec 9 2004 | ISIS | Isis Pharmaceuticals Inc | Lowenstam Patricia | VP | 8,696 | Option exercise at $4.00 | $34,784 | |
MDec 9 2004 | ISIS | Isis Pharmaceuticals Inc | Lowenstam Patricia | VP | 8,696 | Sale at $6.04 | $52,561 | |
MDec 6 2004 | ISIS | Isis Pharmaceuticals Inc | Lowenstam Patricia | VP | 8,000 | Option exercise at $3.76 | $30,076 | |
MDec 6 2004 | ISIS | Isis Pharmaceuticals Inc | Lowenstam Patricia | VP | 8,000 | Sale at $5.81 | $46,498 | |
Dec 3 2004 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 4,817 | Option exercise at $5.88 | $28,300 | |
Dec 3 2004 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 4,817 | Sale at $6.32 | $30,429 | |
MDec 1 2004 | ISIS | Isis Pharmaceuticals Inc | Lowenstam Patricia | VP | 22,304 | Option exercise at $3.75 | $83,640 | |
MDec 1 2004 | ISIS | Isis Pharmaceuticals Inc | Lowenstam Patricia | VP | 22,304 | Sale at $5.52 | $123,154 | |
Jul 1 2004 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 2,920 | Other Purchase at $4.86 | $14,197 | |
Jul 1 2004 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 295 | Other Purchase at $4.86 | $1,434 | |
Jul 1 2004 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP | 272 | Other Purchase at $4.86 | $1,322 | |
Jul 1 2004 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 1,303 | Other Purchase at $4.86 | $6,335 | |
Jul 1 2004 | ISIS | Isis Pharmaceuticals Inc | Stein Aron | VP | 600 | Other Purchase at $4.86 | $2,917 | |
May 14 2004 | ISIS | Isis Pharmaceuticals Inc | Gabrieli Christopher | Director | 20,000 | Option exercise at $6.38 | $127,500 | |
MMay 14 2004 | ISIS | Isis Pharmaceuticals Inc | Gabrieli Christopher | Director | 20,000 | Sale at $6.72 | $134,358 | |
Apr 27 2004 | ISIS | Isis Pharmaceuticals Inc | De Haan Hans A | VP, Drug Development | 5,600 | Sale at $9.80 | $54,880 | |
Apr 27 2004 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 2,400 | Sale at $9.02 | $21,638 | |
Mar 10 2004 | ISIS | Isis Pharmaceuticals Inc | Lundstedt Karen S | VP | 1,000 | Option exercise at $6.81 | $6,810 | |
Mar 10 2004 | ISIS | Isis Pharmaceuticals Inc | Lundstedt Karen S | VP | 1,000 | Sale at $9.31 | $9,310 | |
MMar 5 2004 | ISIS | Isis Pharmaceuticals Inc | Lundstedt Karen S | VP | 15,000 | Option exercise at $6.81 | $102,150 | |
MMar 5 2004 | ISIS | Isis Pharmaceuticals Inc | Lundstedt Karen S | VP | 15,000 | Sale at $9.21 | $138,136 | |
MMar 5 2004 | ISIS | Isis Pharmaceuticals Inc | Cole Douglas L | VP | 62,000 | Option exercise at $3.80 | $235,500 | |
MMar 5 2004 | ISIS | Isis Pharmaceuticals Inc | Cole Douglas L | VP | 62,000 | Sale at $9.21 | $571,053 | |
MMar 5 2004 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 6,666 | Gift at $0.00 | $0 | |
Feb 11 2004 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 2,582 | Option exercise at $4.00 | $10,328 | |
Feb 11 2004 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 2,582 | Sale at $9.06 | $23,400 | |
Jul 1 2003 | ISIS | Isis Pharmaceuticals Inc | Holmlund Jon T | VP | 983 | Other Purchase at $4.39 | $4,320 | |
Feb 6 2004 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 6,368 | Option exercise at $4.00 | $25,472 | |
MFeb 6 2004 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 7,368 | Sale at $8.70 | $64,099 | |
MFeb 2 2004 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 3,200 | Option exercise at $4.00 | $12,800 | |
MFeb 2 2004 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 5,700 | Sale at $9.09 | $51,803 | |
MJan 28 2004 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 10,000 | Sale at $9.03 | $90,325 | |
Jan 27 2004 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP | 750 | Gift at $0.00 | $0 | |
MJan 23 2004 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 12,000 | Sale at $8.50 | $102,055 | |
Jan 21 2004 | ISIS | Isis Pharmaceuticals Inc | Lowenstam Patricia | VP | 20,000 | Option exercise at $3.75 | $75,000 | |
Jan 21 2004 | ISIS | Isis Pharmaceuticals Inc | Lowenstam Patricia | VP | 20,000 | Sale at $8.12 | $162,424 | |
Jan 21 2004 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 1,000 | Sale at $8.12 | $8,121 | |
MJan 20 2004 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 15,500 | Sale at $7.76 | $120,255 | |
MJan 14 2004 | ISIS | Isis Pharmaceuticals Inc | Crooke Stanley T | Chairman, President, CEO | 12,500 | Sale at $7.52 | $94,045 | |
Jan 14 2004 | ISIS | Isis Pharmaceuticals Inc | Wender Joseph H | Director | 20,000 | Option exercise at $6.50 | $130,000 | |
Jan 14 2004 | ISIS | Isis Pharmaceuticals Inc | Wender Joseph H | Director | 20,000 | Sale at $7.46 | $149,264 | |
Jan 1 2004 | ISIS | Isis Pharmaceuticals Inc | Stein Aron | VP-Regulatory Affairs, Quality | 936 | Other Purchase at $4.46 | $4,177 | |
Jan 1 2004 | ISIS | Isis Pharmaceuticals Inc | Parshall B Lynne | EVP, CFO, Secretary | 2,219 | Other Purchase at $4.46 | $9,902 | |
Jan 1 2004 | ISIS | Isis Pharmaceuticals Inc | Lundstedt Karen S | VP, Corporate Communications | 1,942 | Other Purchase at $4.46 | $8,666 | |
Jan 1 2004 | ISIS | Isis Pharmaceuticals Inc | Levin Arthur A | VP, Development | 442 | Other Purchase at $4.46 | $1,972 | |
Jan 1 2004 | ISIS | Isis Pharmaceuticals Inc | Holmlud Jon T | VP, Development | 934 | Other Purchase at $4.46 | $4,168 | |
Jan 1 2004 | ISIS | Isis Pharmaceuticals Inc | Cole Douglas L | VP, Technical Development | 398 | Other Purchase at $4.46 | $1,776 | |
Jan 1 2004 | ISIS | Isis Pharmaceuticals Inc | Bennett C Frank | VP | 481 | Other Purchase at $4.46 | $2,146 | |
MSep 9 2003 | ISIS | Isis Pharmaceuticals Inc | Ecker David J | VP | 11,428 | Gift at $0.00 | $0 | |
Aug 22 2003 | ISIS | Isis Pharmaceuticals Inc | Gabrieli Christopher | Director | 678 | Sale at $5.86 | $3,973 | |
MAug 19 2003 | ISIS | Isis Pharmaceuticals Inc | Gabrieli Christopher | Director | 21,000 | Sale at $5.86 | $122,992 | |
MJul 24 2003 | ISIS | Isis Pharmaceuticals Inc | Garieli Christopher | Director | 59,401 | Sale at $5.06 | $300,402 |
D Derivative transaction exists
M Multiple transactions summarized; earliest reported transaction date and average weighted transaction price
Yahoo Finance